Abstract：Objective To detect and analyze the genetic variation in exon 7 of lung surfactant protein B (SPB), and to investigate the relationship between the genetic variation and the incidence of neonatal respiratory distress syndrome (NRDS) in Han populations in western Inner Mongolia. Methods In the case-control study, 47 Han infants with NRDS were assigned to case group. All the 47 patients had the last three generations of their ancestors reside in western Inner Mongolia. Forty-seven Han newborns without NRDS were assigned to control group. PCR-based gene analysis was used to determine the mutation in exon 7 of SP-B gene and genotype and allele frequencies of the R236C site in exon 7 of SP-B gene. Results In Han newborns in western Inner Mongolia, there was no mutation in exon 7 of SP-B gene; two genotypes, CC and CT, were identified in the R236C site in exon 7 of SP-B gene. No TT genotype was found in the two groups. There were no significant differences in the genotype frequency of CC or CT as well as the allele frequency of C or T between the case and control groups (CC:72% vs 85%, P > 0.05; CT:28% vs 15%, P > 0.05; C:85% vs 93%, P > 0.05; T:15% vs 7%, P > 0.05). Conclusions There is no mutation in exon 7 of SP-B gene in Han infants with NRDS in western Inner Mongolia. There is no significant association between the gene polymorphism of the R236C site in exon 7 of SP-B gene and the incidence of NRDS in Han populations in that region.
WANG Jing,MEI Hua,LIU Chun-Zhi et al. Relationship between R236C site in exon 7 of SP-B gene and respiratory distress syndrome in Han newborns in western Inner Mongolia[J]. CJCP, 2016, 18(9): 802-805.
Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2010 update[J]. Neonatology, 2010, 97(4):402-417.
[2]
Albert RK. The role of ventilation-induced surfactant dysfunction and atelectasis in causing acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2012, 185(7):702-708.
[3]
Hamvas A, Heins HB, Guttentag SH, et al. Developmental and genetic regulation of human surfactant protein B in vivo[J]. Neonatology, 2009, 95(2):117-124.
[4]
Glasser JR, Mallampalli RK. Surfactant and its role in the pathobiology of pulmonary infection[J]. Microbes Infect, 2012, 14(1):17-25.
[5]
Ballard PL, Nogee LM, Beers MF, et al. Partial deficiency of surfactant protein B in an infant with chronic lung disease[J]. Pediatrics, 1995, 96(6):1046-1052.
[6]
Akella A, Deshpande SB. Pulmonary surfactants and their role in pathophysiology of lung disorders[J]. Indian J Exp Biol, 2013, 51(1):5-22.
[7]
Mailaparambil B, Krueger M, Heizmann U, et al. Genetic and epidemiological risk factors in the development of bronchopulmonary dysplasia[J]. Dis Markers, 2010, 29(1):1-9.
[8]
Wilder MA. Surfactant protein B deficiency in infants with respiratory failure[J]. J Perinat Neonatal Nurs, 2004, 18(1):61-67.
[9]
Nogee LM. Alterations in SP-B and SP-C expression in neonatal lung disease[J]. Annu Rev Physiol, 2004, 66:601-623.
[10]
Clark H, Clark LS. The genetics of neonatal respiratory disease[J]. Semin Fetal Neonatal Med, 2005, l0(3):271-282.
Boggaram V. Regulation of lung surfactant protein gene expression[J]. Front Biosci, 2003, 8:d751-d764.
[13]
Dahmer MK, O'cain P, Patwari PP, et al. The influence of genetic variation in surfactant protein B on severe lung injury in African American children[J]. Crit Care Med, 2011, 39(5):1138-1144.
[14]
Wegner DJ, Hertzberg T, Heins HB, et al. A major deletion in the surfactant protein-B gene causing lethal respiratory distress[J]. Acta Paediatr, 2007, 96(4):516-520.
